This study investigates advanced pancreatic cancer. The purpose of this study is to evaluate the safety, tolerability, and effectiveness of an investigational medication combined with chemotherapy.
The study focuses on assessing how well the investigational medication works with chemotherapy to treat advanced pancreatic cancer. It evaluates the overall safety and how patients respond to the treatment.
- Who can participate: Adults aged 18 or older with advanced pancreatic cancer that cannot be surgically removed may participate. Participants should have a CLDN18.2-positive test result and not be eligible for radical treatment.
- Study details: Participants will receive an investigational medication combined with chemotherapy. Some participants may receive a placebo, which is an inactive substance that looks like the investigational medication but does not contain any medicine.